Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 1,532,981 | 1,897,646 | 1,724,324 | 1,603,349 | 1,667,012 | 8,425,312 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 1,532,981 | 1,897,646 | 1,724,324 | 1,603,349 | 1,667,012 | 8,425,312 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | 4,379,401 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 4,045,911 | |||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 1,532,981 | 1,897,646 | 1,724,324 | 1,603,349 | 1,667,012 | 8,425,312 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 58 | 88 | 900 | 9,083 | 27,434 | 37,563 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 1,924 | 106 | 2,030 | |||
| 11 | Total support. Add lines 7 through 10 | 8,464,905 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2018 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2018 |
(iii) Distributable Amount for 2018 |
|
|---|---|---|---|---|
|
1
Distributable amount for 2018 from Section C, line 6 |
||||
|
2
Underdistributions, if any, for years prior to 2018 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2018: | ||||
| a From 2013....... | ||||
| b From 2014....... | ||||
| c From 2015....... | ||||
| d From 2016....... | ||||
| e From 2017....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2018 distributable amount | ||||
|
i
Carryover from 2013 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2018 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2018 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2018, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2018. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2019. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2014...... | ||||
| b Excess from 2015..... | ||||
| c Excess from 2016..... | ||||
| d Excess from 2017..... | ||||
| e Excess from 2018..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990, PART III, LINE 4A | 2018 ACCOMPLISHMENTS: 1. NAME CHANGE AND REBRANDING 2018 WAS A YEAR OF CHANGE! OUR ORGANIZATION REBRANDED TO BIONEXUS KC FROM THE KANSAS CITY AREA LIFE SCIENCES INSTITUTE. WHY BIONEXUS KC? BECAUSE WE ARE THE NEXUS OF ANIMAL AND HUMAN HEALTH AND, AS OUR TAGLINE REFLECTS, WE ARE THE "CATALYST FOR INNOVATION IN ANIMAL AND HUMAN HEALTH." 2. REGIONAL LIFE SCIENCES STRATEGIC ASSESSMENT - "PATH TO 2025" BIONEXUS KC ENGAGED DELOITTE TO EXECUTE A STRATEGIC ASSESSMENT OF THE REGIONAL LIFE SCIENCES IN 2015. THE PROCESS WAS LED BY AN EXPERIENCED STEERING COMMITTEE COMPRISED OF COMMUNITY AND BUSINESS LEADERS IN THE LIFE SCIENCES. THE COMMITTEE LOOKED AT BOTH DRIVERS OF CLUSTER ENHANCEMENT AND REGIONAL SCIENTIFIC STRENGTHS. THE REGIONAL VISION DEVELOPED THROUGH THE ASSESSMENT PROCESS STATES, "THE KANSAS CITY REGION IS A GLOBAL LEADER AT THE NEXUS OF HUMAN AND ANIMAL HEALTH BENEFITING ALL OUR CITIZENS AND THE ECONOMY." THESE NEXUS OPPORTUNITIES WILL BE DIFFERENT FOR EACH STRATEGIC AREA AND WILL LIKELY RANGE FROM USING NATURALLY OCCURRING CANCER IN DOGS FOR ACCELERATING HUMAN DISCOVERIES TO ADVANCING OUR STRENGTH IN HEALTH IT AND OUTCOMES RESEARCH. BIONEXUS KC IS THE "CATALYST FOR INNOVATION IN ANIMAL AND HUMAN HEALTH." WE LEAD PROGRAMS WHERE APPROPRIATE, WE CATALYZE RELATIONSHIPS AND OPPORTUNITIES, AND WE STIMULATE COLLABORATION AND HELP BRING EMERGING TECHNOLOGIES FROM CONCEPT TO REALITY. BIONEXUS KC IS LEADING: - COLLABORATE2CURE TO ENGAGE SCIENTISTS, CLINICIANS AND THE COMMUNITY TO COLLABORATE AND SOLVE VEXING HEALTHCARE AND SCIENTIFIC PROBLEMS - THE DEVELOPMENT OF TWO PROOF OF CONCEPT FUNDS THAT DRIVE COMMERCIALIZATION AND ECONOMIC DEVELOPMENT WHILE SUPPORTING ENTREPRENEURS - REGIONAL WORKFORCE DEVELOPMENT PROGRAMS IDENTIFYING CRITICAL SKILLS NEEDED BY INDUSTRY TO INFORM TIMELY ACADEMIC SOLUTIONS - THE REBRANDING OF BIONEXUS KC AND DEVELOPING A COHESIVE MESSAGE WITH OUR REGIONAL STAKEHOLDERS BIONEXUS KC IS CATALYZING: - THE CANCER WORKING GROUP VISION FOR A REGIONAL VETERINARY CLINICAL TRIAL FACILITY TO OPERATE AT THE NEXUS OF HUMAN AND ANIMAL CANCER AND ACCELERATE NEW THERAPEUTICS FOR PEOPLE AND PETS - PUBLIC/PRIVATE PARTNERSHIPS AND INTEGRATING OUTCOMES RESEARCH GOALS INTO NEURODEVELOPMENTAL DISORDERS (AUTISM SPECTRAL DISORDER) - PARTNERSHIPS IN HUMAN AND ANIMAL HEALTH DATA LEVERAGING OUR REGIONAL HEALTH IT EXPERTISE INTO A PLATFORM CALLED "1DATA" FOR TRANSLATIONAL RESEARCH - REGIONAL INTEREST IN VALUE-BASED HEALTHCARE LEADING A SEA CHANGE OF INNOVATION IN HUMAN HEALTH IMPROVING CLINICAL OUTCOMES AND REDUCING COSTS - A REGIONAL DEMENTIA CARE NETWORK 3. COLLABORATE2CURE BIONEXUS KC CREATED THE COLLABORATE2CURE PROGRAM WITH THE GOAL OF STIMULATING REGIONAL SCIENTIFIC COLLABORATION AND DEVELOPING INNOVATIVE WAYS TO SOLVE SCIENTIFIC CHALLENGES. BIONEXUS KC IDENTIFIES A TOPIC WITH SIGNIFICANT INTEREST TO RESEARCHERS WHICH ALIGNS WELL WITH REGIONAL EXPERTISE, AND THEN COORDINATES A SERIES OF PRESENTATIONS FROM RESEARCHERS OVER THE COURSE OF SEVERAL MONTHS. THE 2018 COLLABORATE2CURE (C2C) SERIES FOCUSED ON "VALUE-BASED HEALTHCARE AND QUALITY OUTCOMES." THIS SERIES WAS CO-CHAIRED BY DRS. STACY FARR AND CAROLE DECKER FROM THE UNIVERSITY OF MISSOURI-KANSAS CITY (UMKC) SCHOOL OF NURSING & HEALTH STUDIES AND SAINT LUKE'S MID AMERICA HEART INSTITUTE (MAHI), RESPECTIVELY. THE TWO, ALONG WITH DR. JOHN SPERTUS (UMKC, MAHI), ARE LEADING THE REGIONAL QUALITY & VALUE INNOVATION CONSORTIUM (QVIC), WHOSE VISION IS TO BRING MULTIPLE STAKEHOLDERS TOGETHER TO IMPROVE THE QUALITY AND VALUE OF HEALTHCARE. THE QVIC IS MADE POSSIBLE THROUGH THE REGIONAL, NIH-FUNDED, FRONTIERS: CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (CTSI) ADMINISTERED BY THE UNIVERSITY OF KANSAS. MULTIPLE KEY STAKEHOLDERS GATHERED DURING THIS SERIES, INCLUDING RESEARCHERS, HEALTHCARE PROVIDERS, QUALITY IMPROVEMENT PROFESSIONALS, COMMERCIAL AND PUBLIC HEALTH INSURERS, STUDENTS, PATIENTS, ENTREPRENEURS, COMMUNITY-BASED ORGANIZATIONS, AND THE DEPARTMENT OF HEALTH. THIS C2C SERIES PROVIDED TWO DIFFERENT SESSIONS, WITH OVER 300 ATTENDEES PARTICIPATING IN 2018. THE FIRST SESSION WAS A MONTHLY GENERAL MEETING ON KEY HEALTHCARE TOPICS IDENTIFIED AS STRATEGIC PRIORITIES BY HEALTHCARE LEADERSHIP THROUGHOUT THE KC REGION. THE GENERAL SESSIONS FEATURED MULTIPLE KEY STAKEHOLDERS AS THEY PRESENTED TOPICS AND CHALLENGES FROM THEIR PERSPECTIVE (INSURER, HOSPITAL, RESEARCHER, PATIENT, AND/OR CBO), FOLLOWED BY A ROUNDTABLE DISCUSSION TO IDENTIFY OPPORTUNITIES TO COLLABORATE AND ADDRESS THESE CHALLENGES. IN ADDITION TO THE GENERAL C2C SESSIONS, A SECOND MEETING SERIES FOCUSED SPECIFICALLY ON THE RESEARCH COMMUNITY. THE C2C RESEARCHER MEETINGS WERE BI-MONTHLY, BRINGING TOGETHER OUTCOMES RESEARCHERS TO EVALUATE THE HEALTHCARE CHALLENGES DISCUSSED IN THE GENERAL C2C SESSIONS. RESEARCHERS WERE TASKED WITH DEVELOPING MEANINGFUL INTERVENTION STRATEGIES TO IMPROVE THE QUALITY AND VALUE OF HEALTHCARE FOR IMPLEMENTATION IN A MULTI-HOSPITAL NETWORK. THE C2C RESEARCHER MEETINGS ENGAGED RESEARCHERS IN INNOVATION AND BUILDING A STRONGER RESEARCH COMMUNITY ACROSS THE INTER-DISCIPLINARY FIELD OF HEALTH SERVICES RESEARCH AND HEALTHCARE QUALITY IMPROVEMENT. A SIGNIFICANT OUTCOME OF THIS YEAR'S COLLABORATE2CURE SERIES IS THAT TWO PROJECTS ARE BEING FORMULATED TO ENGAGE MULTIPLE HEALTH SYSTEMS IN A TWO-YEAR VALUE-IMPROVEMENT PROJECT, SUPPORTED BY THE RESEARCH COMMUNITY: - A PROGRAM ADDRESSING THE OPIOID EPIDEMIC - A PROGRAM ON TRANSITIONS IN CARE, FOCUSING ON HEART FAILURE, THAT WILL LEVERAGE OUR INSIGHTS INTO PATIENTS' EXPERIENCES AND ADDRESSING THE SOCIAL DETERMINANTS OF HEALTH. WHILE THE ENTIRE COUNTRY IS GRAPPLING WITH THE CHALLENGE OF IMPROVING THE QUALITY OF CARE WHILE LOWERING COSTS, KANSAS CITY CAN MODEL THE UNIQUE CULTURE AND ASSETS OF OUR REGION AS IT STRIVES TO BECOME "THE OUTCOMES CAPITOL". |
| FORM 990, PART III, LINE 4A | (CONTINUED) 4. WORKFORCE DEVELOPMENT WORKFORCE DEVELOPMENT WAS IDENTIFIED IN BIONEXUS KC'S PATH TO 2025 REPORT AS A SIGNIFICANT THREAT TO, AND CRITICAL WEAKNESS IN, THE REGIONAL LIFE SCIENCE CLUSTER. KC RISING, A CIVIC INITIATIVE UNDERWAY ACROSS THE KANSAS CITY COMMUNITY, ESTABLISHED A HUMAN CAPITAL WORK GROUP TO ADDRESS WORKFORCE DEVELOPMENT ISSUES. RECOGNIZING THE OPPORTUNITY TO LEVERAGE A PARALLEL EFFORT, BIONEXUS KC INTEGRATED ITS EFFORTS AND EXPERTISE WITH KC RISING TO DEVELOP A REGIONAL PLAN OF ACTION. 2018 ACTIVITIES IN SUPPORT OF WORKFORCE DEVELOPMENT INCLUDED THE FOLLOWING: - A KEY RECOMMENDATION FROM THE LIFE SCIENCES TALENT TO INDUSTRY EXCHANGE (TIE) PROCESS, CONDUCTED AS PART OF KC RISING, WAS TO ESTABLISH A REGIONAL ADVISORY COUNCIL (RAC). THE RAC CAN ASSESS A VARIETY OF WORKFORCE ISSUES AND IDENTIFY EDUCATION SOLUTIONS MORE RAPIDLY, EFFICIENTLY, AND MEETING INDUSTRY NEEDS. - BIOINFORMATICS WAS SELECTED AS THE FIRST FOCUS AREA FOR THE RAC, AS COMPANIES IN THIS INDUSTRY SECTOR STRUGGLE TO ACQUIRE ADEQUATELY SKILLED WORKERS. THE RAC IS CO-CHAIRED BY BARBARA BICHELMEYER (PROVOST, UMKC) AND HARLEN HAYS (MANAGER, LEAD ANALYTICS ADVISER, CERNER). THE GROUP WORKS CLOSELY WITH CERNER, NETSMART, AND IQVIA - COMPANIES EMPLOYING 80% OF THE BIOINFORMATICS WORKFORCE. - CONTRACT RESEARCH ORGANIZATIONS WILL BE THE SECOND FOCUS AREA. GIVEN THE EVER-CHANGING NATURE OF THEIR WORKFLOW, THIS INDUSTRY SECTOR IS RIPE FOR USING STACKABLE CREDENTIALS TO MEET TRAINING NEEDS. THESE SHORT-TERM CREDENTIALS CAN BE "STACKED," LEADING TO TWO AND FOUR-YEAR DEGREES. - THE EMERGING ENTREPRENEUR PROOF OF CONCEPT FUND (E2POC). THE GOAL OF THE EMERGING ENTREPRENEUR PROOF OF CONCEPT FUND (E2POC) IS TO SUPPORT OUR REGION'S YOUNG EMERGING ENTREPRENEURS AND SECURE EVOLVING TECHNOLOGIES FOR REGIONAL ECONOMIC DEVELOPMENT. THE E2POC PROGRAM INVESTS IN EARLY-STAGE, HIGH POTENTIAL TECHNOLOGIES DEVELOPED BY STUDENTS PARTICIPATING IN REGIONAL STEM COMPETITIONS. TO INCREASE ENTREPRENEURS IN THE REGION, THE E2POC PROGRAM STRENGTHENS STUDENT INVENTORS THROUGH ONLINE RESOURCES, BUSINESS PLAN DEVELOPMENT ASSISTANCE, MARKET ASSESSMENTS, INTELLECTUAL PROPERTY PROTECTION, AND ACCESS TO CAPITAL. IN THE PROGRAM, STUDENTS WILL RECEIVE $5,000 PER YEAR IN SCHOLARSHIP MONEY (UP TO $20,000 TOTAL). THE E2POC WILL FUND THE WORK AND PATENT FEES. THE ENTREPRENEUR IS PAIRED WITH BUSINESS MENTORS TO AUGMENT THEIR ENTREPRENEURIAL EDUCATION. LOCAL UNIVERSITIES AND COLLEGES HAVE COMMITTED TO MATCHING THE E2POC SCHOLARSHIP FUNDS, PROVIDING A STRONG INCENTIVE FOR THESE STUDENTS TO STAY IN THE REGION. 5. BIONEXUS KC'S RESEARCH DEVELOPMENT GRANT PROGRAMS BIONEXUS KC'S RESEARCH DEVELOPMENT GRANTS PROGRAM IS OUR OLDEST AND MOST POPULAR PROGRAM. GRANTS ARE AWARDED TO GENERATE PRELIMINARY DATA THAT SUPPORT SUBMISSION OF MAJOR MULTIDISCIPLINARY RESEARCH PROPOSALS TO GOVERNMENT OR PRIVATE FUNDING AGENCIES. APPLICANTS RECEIVE WRITTEN PEER REVIEWS, REGARDLESS OF WHETHER THEIR PROJECT RECEIVED FUNDING, TO HELP THEM IMPROVE FUTURE GRANT APPLICATIONS. THIS IS A VALUED SERVICE APPRECIATED BY ALL TEN STAKEHOLDERS. FROM 2007 TO 2018, BIONEXUS KC MANAGED 108 GRANTS TOTALING $5 MILLION. ON AVERAGE, FOR EVERY $1 INVESTED IN GRANTS, $11.70 HAS BEEN RETURNED TO THE REGION FROM FOLLOW-ON FEDERAL SOURCES. IMPORTANTLY, THIS NUMBER SHOULD BE VIEWED CONSERVATIVELY AS NO INFORMATION IS READILY AVAILABLE REGARDING GRANTS MADE TO REGIONAL SCIENTISTS BY PRIVATE FOUNDATIONS AND PATIENT ADVOCACY ORGANIZATIONS. THE 2018 BIONEXUS KC RESEARCH DEVELOPMENT GRANT PORTFOLIO INCLUDES: BLUE KC OUTCOMES RESEARCH GRANTS BCBS ANNOUNCED IN 2018 THAT THEY WOULD BE CHANGING THEIR APPROACH IN FUTURE GRANTS. IN 2019, BIONEXUS KC WILL WORK WITH BCBS IN SEEKING HIGHER COMMUNITY IMPACT FOR THEIR GRANT PROGRAM BY OFFERING ONE $400,000 GRANT OVER TWO YEARS FOR PROJECTS ASSESSING THE IMPACT OF ACCESS TO HEALTHFUL FOODS ON FOOD INSECURE POPULATIONS. PAUL PATTON CHARITABLE TRUST GRANTS FOCUS ON GENETIC DISEASES MAINLY AFFECTING CHILDREN. THE FUNDS FOR THIS PROGRAM ARE PROVIDED BY THE PAUL PATTON TRUST, TED C. MCCARTER, WILLIAM EVANS JR. AND BANK OF AMERICA, N.A., TRUSTEE. BIONEXUS KC AWARDED GRANTS OF UP TO $50,000 TO THREE RESEARCHERS, TWO AT CHILDREN'S MERCY, AND ONE AT THE UNIVERSITY OF KANSAS MEDICAL CENTER. NEXUS OF HUMAN AND ANIMAL HEALTH GRANTS FOCUS ON BIOMEDICAL RESEARCH PROJECTS, RANGING FROM USING NATURALLY OCCURRING DISEASES IN ANIMALS AS A MODEL FOR ASSESSING HUMAN DRUG EFFICACY TO REPURPOSING HUMAN DRUGS FOR USE IN ANIMAL DISEASES. FUNDED BY THE HALL FAMILY FOUNDATION, BIONEXUS KC AWARDED $50,000 GRANTS EACH TO THREE RESEARCHERS, ONE EACH TO KANSAS STATE UNIVERSITY, THE UNIVERSITY OF MISSOURI, AND UNIVERSITY OF KANSAS. 6. 2018 ANNUAL DINNER AND "SCIENCE TO ART" AUCTION CLOSE TO 500 COMMUNITY LEADERS, SCIENTIFIC LEADERS, AND COLLEGE AND HIGH SCHOOL STUDENTS ATTENDED THE SEPTEMBER 20, 2018 ANNUAL DINNER. DR. DAVID NASH, DEAN OF THE JEFFERSON COLLEGE OF POPULATION HEALTH AT THOMAS JEFFERSON UNIVERSITY. HIS PRESENTATION, 'LEADERSHIP FOR IMPROVING HEALTH,' EXPLAINED ALARMING TRENDS IN POPULATION HEALTH. "FOR THE FIRST TIME SINCE THE END OF WWII, THE NEXT GENERATION ARE AT RISK OF HAVING A SHORTER LIFESPAN THAN FOLKS BORN AROUND 1950," DR. NASH SAID. SPECIFICALLY, IN KANSAS CITY, THERE IS A 14-YEAR DISPARITY IN LIFE EXPECTANCY BETWEEN THE POOREST AND WEALTHIEST ZIP CODES. SOCIAL DETERMINANTS OF HEALTH, SUCH AS POVERTY AND EDUCATION, ARE A VERY IMPORTANT PART OF DRIVING THE LEVEL OF WELLNESS IN A SOCIETY. DR. WAYNE CARTER, PRESIDENT AND CEO FOR THE PAST SIX YEARS WAS HONORED FOR HIS CONTRIBUTION TO THE LIFE SCIENCES REGION. THE FIFTH SCIENCE TO ART SILENT AUCTION RAISED OVER $5,000 WHICH WAS MATCHED BY BIONEXUS KC TO SUPPORT STEAM EDUCATION, SPECIFICALLY BIOGENEIUS, PREP-KC, SCIENCE CITY AND THE GREATER KANSAS CITY SCIENCE & ENGINEERING FAIR, AND FREE EDUCATIONAL PROGRAMS AT THE KEMPER MUSEUM. 7. ONE HEALTH - NEXUS PROOF OF CONCEPT FUND: THE NEXUS OF ANIMAL AND HUMAN HEALTH PROOF OF CONCEPT FUND IDENTIFIES AND DEVELOPS TECHNOLOGIES AT THE NEXUS OF ANIMAL AND HUMAN HEALTH. BASED ON THE SUCCESSFUL MODEL OF THE CENTER FOR ANIMAL HEALTH AND INNOVATION, INVESTMENTS UP TO $250,000 WILL BE INVESTED TO DE-RISK PROMISING TECHNOLOGY TO STIMULATE ADDITIONAL INVESTMENT. - ONE HEALTH RESEARCH SYMPOSIUM: THE 2018 ONE HEALTH RESEARCH SYMPOSIUM FOCUSED ON ONE HEALTH APPLICATIONS OF CRISPR/CAS9, A GENE EDITING TECHNOLOGY WITH THE POTENTIAL OF TRANSFORMING GLOBAL HEALTH. ITS MANY APPLICATIONS INCLUDE CORRECTING GENETIC DEFECTS, TREATING AND PREVENTING THE SPREAD OF DISEASES AND IMPROVING CROPS. - BIONEXUS KC COORDINATED THIS TWO-DAY EVENT ALONG WITH THE UNIVERSITY OF MISSOURI, KANSAS STATE UNIVERSITY AND INDUSTRY PARTNERS. THE SYMPOSIUM FEATURED OVER 20 NATIONAL AND REGIONAL EXPERTS ADDRESSING THIS TOPIC. CRISPR STANDS FOR CLUSTERS OF REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS AND IS AN IMMUNE FUNCTION THAT BACTERIA USE TO FIGHT VIRUSES. THERE WERE SEVERAL APPLICATIONS PRESENTED INCLUDING: - USING CRISPR FOR DUCHENNE MUSCULAR DYSTROPHY AND IN PRECISION CANCER MEDICINE. - CRISPR APPROACH TO IMPROVE ANIMAL WELFARE, SUSTAINABILITY AND FOOD SECURITY. - INTELLECTUAL PROPERTY AND ETHICAL IMPLICATIONS OF GENE EDITING. - ONE HEALTH DAY: BIONEXUS KC PARTNERED WITH KANSAS STATE UNIVERSITY AND BIOKANSAS TO HOST "KANSAS CITY ONE HEALTH DAY." A KEYNOTE PRESENTATION WAS GIVEN BY DR. MIKE APLEY FROM KANSAS STATE UNIVERSITY ENTITLED 'ANTIBIOTIC RESISTANCE - A ONE HEALTH PERSPECTIVE.' THE EVENT INCLUDED A STUDENT POSTER COMPETITION AND AN EXPERT PANEL THAT EXPLORED ANTIMICROBIAL RESISTANCE THROUGH A ONE HEALTH LENS AND ANSWERED QUESTIONS FROM THE AUDIENCE. THE PANELISTS WERE MIKE APLEY, PHD, DVM, DACVCP, KANSAS STATE UNIVERSITY, MICHAEL MEYER, PHD, U.S. GEOLOGICAL SURVEY, NADYNE HAGMEIER, RN, KANSAS FOUNDATION FOR MEDICAL CARE INC. AND MASAKO MIZUSAWA, MD, PHD, MS, UNIVERSITY OF MISSOURI-KANSAS CITY. DR. KEITH GARY, VICE PRESIDENT OF BIONEXUS KC, CONCLUDED THE EVENT BY AWARDING FIVE STUDENTS SCHOLARSHIPS IN RECOGNITION OF THEIR ONE HEALTH-FOCUSED RESEARCH POSTERS. THESE AWARDS WERE FUNDED BY BIOKANSAS. |
| FORM 990, PART III, LINE 4A | (CONTINUED) 8. BIOINFORMATICS IN PARTNERSHIP WITH CHILDREN'S MERCY AND THE UNIVERSITY OF MISSOURI, BIONEXUS KC PRESENTED THE THIRD ANNUAL MIDWEST BIOINFORMATICS CONFERENCE ON APRIL 11-12, 2018. FEATURING 31 SPEAKERS, THIS EVENT BROUGHT TOGETHER NEARLY 200 BIOINFORMATICS-MINDED RESEARCHERS FROM ACADEMIA AND INDUSTRY TO DISCOVER CAPABILITIES, SHARE TACTICAL APPROACHES TO PROBLEM-SOLVING, AND EXPLORE SYNERGIES AND POTENTIAL COLLABORATIONS. THE CONFERENCE WAS HOSTED ON THE UNIVERSITY OF MISSOURI CAMPUS. ADDITIONALLY, BIOINFORMATICS STUDENTS LEARNED ABOUT EMPLOYMENT OPPORTUNITIES WITHIN THE REGION AND PARTICIPATED IN MOCK INTERVIEWS. INTRODUCED THIS YEAR, A SUBSET OF 33 STUDENT POSTERS WAS CONSIDERED FOR PODIUM PRESENTATIONS, WITH FOUR STUDENTS SELECTED FOR THIS HONOR. KEYNOTE SPEAKERS WERE JOHNNY PARK, PHD, FOUNDER AND CEO OF SPENCA TECHNOLOGIES, "PRECISION AG - THE NEXT REVOLUTION IN AGRICULTURE TO FEED 10 BILLION PEOPLE IN 2050 AND MARYLYN DR. RITCHIE, PHD, PRINCIPAL INVESTIGATOR, DIRECTOR, CENTER FOR TRANSLATIONAL BIOINFORMATICS, INSTITUTE FOR BIOMEDICAL INFORMATICS, ASSOCIATE DIRECTOR FOR BIOINFORMATICS, INSTITUTE FOR BIOMEDICAL INFORMATICS, ASSOCIATE DIRECTOR, CENTER FOR PRECISION MEDICINE AT THE UNIVERSITY OF PENNSYLVANIA, "MACHINE LEARNING STRATEGIES IN THE GENOME AND THE PHENOME - TOWARD A BETTER UNDERSTANDING OF COMPLEX TRAITS". |
| FORM 990, PART VI, SECTION A, LINE 2 | ANNE D. ST. PETER AND STEVEN ST. PETER,MD HAVE A FAMILY RELATIONSHIP. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE ORGANIZATION HAS A POLICY FOR THE ORGANIZATION'S AUDIT COMMITTEE TO REVIEW THE 990 BEFORE IT IS FILED. |
| FORM 990, PART VI, SECTION B, LINE 12C | ALL STAFF AND DIRECTORS MUST SUBMIT ANY CONFLICTS OF INTEREST ON AN ANNUAL BASIS. IF A CONFLICT ARISES WITHIN THE BOARD, THE DISCLOSING INDIVIDUAL SHALL NEITHER VOTE NOR ENDEAVOR TO INFLUENCE THE DECISION. |
| FORM 990, PART VI, SECTION B, LINE 15A | COMPENSATION OF THE ORGANIZATION'S PRESIDENT IS AGREED UPON BY THE BOARD OF DIRECTORS AND FINALIZED VIA A WRITTEN EMPLOYMENT CONTRACT. THIS APPROVAL IS DOCUMENTED IN THE MINUTES OF THE BOARD. IN 2013 THE ORGANIZATION CREATED A COMPENSATION COMMITTEE AND CONDUCTED A COMPENSATION STUDY TO FURTHER REFINE THE COMPENSATION PROCESS. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE ONLY AVAILABLE UPON REQUEST. |
| Software ID: | |
| Software Version: |